Comparison of topical tofacitinib and 0.1% hypochlorous acid in a murine atopic dermatitis model

BACKGROUND: Topical administration of PR022, 0.05% hypochlorous acid (HOCl) in gel has been demonstrated to be beneficial in a chronic murine atopic dermatitis model. In a follow up study we tested a higher concentration (0.1%) of PR022 HOCl gel in comparison to the Janus kinase inhibitor tofacitini...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukuyama, Tomoki, Ehling, Sarah, Wilzopolski, Jenny, Bäumer, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029395/
https://www.ncbi.nlm.nih.gov/pubmed/29970189
http://dx.doi.org/10.1186/s40360-018-0232-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029395/
https://www.ncbi.nlm.nih.gov/pubmed/29970189
http://dx.doi.org/10.1186/s40360-018-0232-3

Ejemplares similares